Forward to a Friend
You may enter up to five email addresses here, on separate lines. A preview of the email has been included below. Each address will receive a copy of the email as seen in the preview.

 

Preview



Having trouble viewing this email? View as a web page.

 
Get updates on the CARDINAL Phase 2/3 Study 
 
 
Dear Friends,
 
Join Mr. Warren Huff, CEO of Reata Pharmaceuticals, for one of two upcoming meetings to discuss the CARDINAL clinical trial in more detail.
 
Reata will be hosting the online Webex meetings in September to discuss recent CARDINAL Phase 2 data plus study updates and next steps for the ongoing Phase 3 portion of CARDINAL. Reata is evaluating the safety and effectiveness of an investigational medication, bardoxolone methyl, in Alport syndrome. 
 
Meeting Dates and Times
There will be two meetings in the next few weeks. The same information will be presented at both meetings, so pick the time that best fits your schedule:
  • Tuesday, September 12 at 10:00am PDT/1:00pm EDT
  • Thursday, September 14 at 5:00pm PST/8:00pm EDT 
Purpose
The purpose of these meetings is to provide an update on the Phase 2 study and introduce the Phase 3 portion of the study to the patient community, including study participation, eligibility criteria, how to enroll, study status, etc. The Webex meetings will include time at the end for Reata to answer questions from the participants.
 
Target Audience
This event is aimed at any interested individuals affected by Alport syndrome and/or family members.
 
What is a Webex Meeting?
A Webex is an online meeting that includes audio and screen sharing. All you need is an internet connection!
 
How to Participate
To register for one of the online Webex meetings, please contact Hanh Nguyen at
Hanh.Nguyen@reatapharma.com. Then simply follow the link provided at the appropriate time.
 
In order to receive the link to join the Webex meeting, you must register in advance.  
 
Recording of Previous Webex Meeting
Additional information about bardoxolone methyl, the medication being used in the study, was presented to the patient community through an online Webex meeting in December 2016. If you would like to listen to the recording of the December meeting, it is available on the ASF YouTube channel.
 

Would you like to forward this email to a friend? Click here.

Share This Email: Facebook Twitter Digg Myspace Linked In Delicious